| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 136.948 | 79 |
| GSM780708 | Untreated after 4 days (C2_1) | 150.627 | 80 |
| GSM780709 | Untreated after 4 days (C3_1) | 162.578 | 81 |
| GSM780719 | Untreated after 4 days (C1_2) | 139.012 | 80 |
| GSM780720 | Untreated after 4 days (C2_2) | 164.574 | 81 |
| GSM780721 | Untreated after 4 days (C3_2) | 185.01 | 83 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 134.048 | 79 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 154.964 | 81 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 111.192 | 77 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 144.362 | 80 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 147.361 | 80 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 130.052 | 79 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 163.675 | 81 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 137.571 | 79 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 148.788 | 80 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 173.994 | 82 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 161.894 | 81 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 146.343 | 80 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 140.046 | 80 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 182.096 | 83 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 144.948 | 80 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 159.729 | 81 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 141.363 | 80 |